US2011064767A1PendingUtilityA1
Cdna construct of salmonidae alphavirus
Est. expiryJun 21, 2025(expired)· nominal 20-yr term from priority
C12N 2770/36122C12N 2770/36121A61K 2039/552C12N 2770/36151C12N 15/86A61K 39/12C07K 14/005A61P 31/12A61K 2039/53C12N 15/1131A61P 37/02C12N 2310/127C12N 7/00C12N 2310/121A61P 31/20C12N 2770/36134A61P 31/14
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention concerns recombinant DNA's comprising c NDA of genomic RNA of a Salmonidae alphavirus preceded by a spacer sequence, under the control of a suitable promoter. Said recombinant DNA's are useful for obtaining expression vectors, producing recombinant Salmonidae alphavirus, and for obtaining vaccines.
Claims
exact text as granted — not AI-modified1 . A method for preparing a Salmonidae alphavirus RNA replicon, comprising introducing a recombinant DNA in to a host cell and culturing said host cell, wherein the recombinant DNA is derived from a genome of a Salmonidae alphavirus and comprises:
a transcription promoter and, downstream of said promoter and under transcriptional control thereof; a spacer sequence of at least 5 nucleotides; and a cDNA of a genomic RNA of a Salmonidae alphavirus, and the spacer sequence is defined by general formula (I):
(SEQ ID NO: 29)
5′ X 1 CTGANGARX 2 B 2 X′ 2 YGAAAX 3 B 3 X′ 3 TH 3′ (I)
in which A, T, G, and C have their usual meaning; H represents C, T or A; R represents A or G; Y represents C or T; N represents A, T, G or C; X 1 represents an oligonucleotide of at least 3 nucleotides, preferably from 6 to 10 nucleotides, of sequence complementary to that of the 5′ end of the genome of said alphavirus; X 2 represents an oligonucleotide of at least 3 nucleotides, preferably from 3 to 5 nucleotides, of any sequence; B 2 represents an oligonucleotide of 4 or 5 nucleotides, of any sequence; X′ 2 represents an oligonucleotide complementary to X 2 ; X 3 represents an oligonucleotide of at least 2 nucleotides, preferably of 6 to 10 nucleotides, of any sequence; B 3 represents an oligonucleotide of 4 to 5 nucleotides, of any sequence; X′ 3 represents an oligonucleotide complementary to X 3 .
2 . A Salmonidae alphavirus RNA replicon obtained by the method according to claim 1 .
3 . A method for preparing a recombinant Salmonidae alphavirus, comprising introducing a recombinant DNA or an RNA replicon into a host cell in which all structural proteins of said alphavirus that are required for encapsidation are expressed, and culturing said host cell wherein the recombinant DNA is derived from a genome of a Salmonidae alphavirus and comprises:
a transcription promoter and, downstream of said promoter and under transcriptional control thereof; a spacer sequence of at least 5 nucleotides; and a cDNA of a genomic RNA of a Salmonidae alphavirus, and the spacer sequence is defined by general formula (I):
(SEQ ID NO: 29)
5′ X 1 CTGANGARX 2 B 2 X′ 2 YGAAAX 3 B 3 X′ 3 TH 3′ (I)
in which A, T, G, and C have their usual meaning; H represents C, T or A; R represents A or G; Y represents C or T; N represents A, T, G or C; X 1 represents an oligonucleotide of at least 3 nucleotides, preferably from 6 to 10 nucleotides, of sequence complementary to that of the 5′ end of the genome of said alphavirus; X 2 represents an oligonucleotide of at least 3 nucleotides, preferably from 3 to 5 nucleotides, of any sequence; B 2 represents an oligonucleotide of 4 or 5 nucleotides, of any sequence; X′ 2 represents an oligonucleotide complementary to X 2 ; X 3 represents an oligonucleotide of at least 2 nucleotides, preferably of 6 to 10 nucleotides, of any sequence; B 3 represents an oligonucleotide of 4 to 5 nucleotides, of any sequence; X′ 3 represents an oligonucleotide complementary to X 3 , or
introducing the RNA replicon according to claim 5 into a host cell in which all structural proteins of said alphavirus that are required for encapsidation are expressed, and culturing said host cell.
4 . The method according to claim 3 , wherein all genetic information for the expression of said structural proteins is carried by said recombinant DNA or said RNA replicon.
5 . The method according to claim 3 , wherein all or part of genetic information for the expression of said structural proteins is provided in trans by the host cell.
6 . A recombinant Salmonidae alphavirus obtained by a method according to claim 3 .
7 . A method for obtaining a vaccine, incorporating a recombinant Salmonidae alphavirus according to claim 6 into the vaccine.
8 . A vaccine comprising a Salmonidae alphavirus RNA replicon according to claim 2 .
9 . A vaccine comprising a recombinant Salmonidae alphavirus according to claim 6 .Join the waitlist — get patent alerts
Track US2011064767A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.